chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day of vaccination:  Felt good all day.   Night of vaccination:  Very sore arm in middle of the night.  Felt a little groggy in morning.  24 hours after vaccination:  I'm usually cold when sitting at my work desk in my house, but I felt a little goosebumpy with chills, my skin hurt a little (like those slight body aches when you get sick but not a terrible feeling) and I felt a very very faint headache (more like groggy)  Around 30 hours after vaccine:  I felt warmish. Felt a little under the weather all evening, but mostly ok  On the 2nd night after vaccine:  Woke up several times at night with major pain in my left armpit.  It made me afraid, as I did not know if this was something to do with my heart, since in my upper left arm. In the morning (second day after vaccine), i noticed an extremely swollen armpit lymph node.  The ache subsided during the day, but the lymph node remained swollen for the week.  I believe the swelling has significantly reduced by now.   The injection site was very itchy and painful for approx 10 days.  As of today (Day 13 after 2nd vaccination), my arm is still mildly painful if I press on it, but the pain is slowly subsiding.
5mo old pt recvd HIBTITER on 7JUN91 & on 6JUL91, & devel H. Influenza meningitis on 13JUL91; Hospitalized 3 weeks; recovered;
Sensitive teeth. I?ve had sensitive teeth for awhile, but the day after my booster, all my teeth were super sore Instead of just the normal few.
Pt began having itchy papules (2MM) and small vesicles on left arm about 8 days, post vax. Then spread to chest, right arm and abdomen. Pt also, seen for symptoms of asthma. Treated with prednisone and Entex LA.
In the evening of my vaccination date I began to have symptoms of muscle and joint pain lack of strength and fatigue. I did have the flu vaccine on the same day as my COVID-19 Vaccine. The symptoms were much worse on the second day and I was miserable, I spent most of the day in bed napping as a result. The symptoms started to get better after the third day and I finally started to feel back to my normal self. However, since the vaccine my pain has become significantly worse and I am now prescribed codeine to ease the pain. About a week ago I did go to urgent care with what I thought was a UTI, they did take a sample and did not find anything. I was given an antibiotic to treat the symptoms however they did state that there was an issue with the sample. Now I do have mild pain still that is lasting despite finishing my round of antibiotics.
reported muscle pain behind her right knee; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included knee operation (3 operations on left knee including implant and rods), rheumatoid arthritis and shingles (mild case a few years ago from the date of reporting).   On 1st November 2020, the patient received the 1st dose of Shingrix. On 2nd November 2020, 1 days after receiving Shingrix, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was not recovered/not resolved.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left arm. After receiving Shingrix, the patient experienced muscle pain behind her right knee. Till the time of reporting, the patient did not receive 2nd dose. The reporter consented to follow up. The reporter did not know Shingrix lot or expiration date.  She gave consent to email Shingrix PI and was given telephone number to share with her healthcare professional.
5 x 5 cm induration and erythema left arm, 6 x 6 right arm.
This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid-19) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced COVID-19 (tested positive for Covid-19). At the time of the report, COVID-19 (tested positive for Covid-19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 test: positive Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Received its 30-days Exp date; Patient received vaccine past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received its 30-days Exp date) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2022 at 11:57 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 07-Feb-2022 at 11:57 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received its 30-days Exp date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received its 30-days Exp date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient ethnicity was White. No concomitant medication was reported by reporter. Vaccine was in thaw state (2 to 8 degree Celsius) from about 20-Dec-2021. Dose was given at 07-Feb-2022 11:57:33. No treatment medication was reported by reporter.
She had flu like symptoms for 24 hours but no fever and a swollen, hot to the touch arm at the injection site. Her arm is less swollen and less painful but there still is pain (8/22).
No reaction until Monday afternoon. Stomach ache, increasing in pain. By Tuesday evening @ 5pm was unbearable, I felt nauseous, blacked out. My stomach was in agony, pain began radiating up my back, so my husband took me to the ER.  I had blood panels done, all returned normal.   CT scan with and without dye. Doctor came and said that I was diagnosed with enteritis. I've never before had this. He said they don't know why it happened, I was perfectly healthy beforehand and I informed him that I just received my Covid vaccine on Saturday and this was listed by Pfizer as a post-authorisation adverse reaction. No doctor will confirm that it is the reason and be liable so I am unable to be exempt me from the second dose.   1 week from being in the ER and the pain has continued. I am unable to eat, I've lost 8 lbs. I can sip water. No position is comfortable, and no doctor will prescribe pain medication either. They simply say I have to wait for it to go away.   10 days from injection and no sign of the pain going away.  I have another appointment with a doctor 7/20/22.
Patient received this second PREVNAR after receiving one the year prior on 09/25/2016. Patient was due to receive PNEUMOVAX 23 but was given PREVNAR 13 in error.
BODY ACHE; CHILLS; NAUSEA; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced body ache, chills, nausea, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, chills, nausea, and headache. This report was non-serious.
Had an almost metallic-like taste in my mouth on both my first and second shot. Slight burning in the arm only after the second dose.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 25-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07May2021 11:00 (Batch/Lot number: unknown) at the age of 25 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "attention deficit hyperactivity disorder" (unspecified if ongoing). Concomitant medication(s) included: ADDERALL. The following information was reported: DYSGEUSIA (non-serious) with onset 07May2021 11:30, outcome "recovered", described as "Had an almost metallic-like taste in my mouth on both my first and second shot. Slight burning in the arm only after the second dose.". Therapeutic measures were not taken as a result of dysgeusia.  Additional information: The patient had no known allergies. Patient not diagnosed with covid-19 prior to vaccination and since vaccination patient not tested for covid-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tiredness). At the time of the report, FATIGUE (Tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.   This case was linked to MOD-2021-069692 (Patient Link).
This spontaneous report was received from a physician refers to a 48 year old male patient. Patient's concurrent conditions included aortic stenosis, asthma, heart failure, COPD (chronic obstructive pulmonary disease), hypertension, obstructive sleep apnea, restless leg syndrome, hyperlipidemia, implantable cardioverter defibrillator (icd), peripheral artery disease and heart failure. Patient's drug reactions/allergies included Novocaine, PRO AIR. On 02-OCT-2014, the patient was vaccinated with PNEUMOVAX 23 arm (dose, route and lot # were not provided) for to prevent pneumonia. Other suspect therapy included FLUZONE arm. Concomitant therapies included amiodarone (manufacturer unknown), aspirin (manufacturer unknown), carvedilol (manufacturer unknown), PLAVIX, PROZAC, lisinopril (manufacturer unknown), magnesium (manufacturer unknown), metolazone (manufacturer unknown), niacin (manufacturer unknown), PROTONIX, REQUIP, spironolactone, and torsemide. On an unspecified date in October 2014, the patient was seen in the emergency room due to arm swelling, blurred vision, "being feverish at the neck", shortness of breath and ringing of the ears after receiving PNEUMOVAX 23 and FLUZONE "at the same time in the same arm". The reporter did not give any indication the vaccines were mixed in the same syringe. On an unknown date, the patient sought medical attention. The outcome of the vision blurred, "being feverish at the neck", ringing of the ears, shortness of breath and arm swelling was reported as recovered/resolved. Additional information has been requested.
Lt upper arm redness swollen and painful on touch. As early morning as progression into the 12th of November, redness was spreading, more painful and patient felt chills and then felt flushed.
Chronic hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Chronic hives) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21A and 058E21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 04-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced URTICARIA (Chronic hives). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC HIVES RELIEF) (oral) for Urticaria, at a dose of 10 mg and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Urticaria, at a dose of 25 mg. At the time of the report, URTICARIA (Chronic hives) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.      The dermatologist will do a biopsy in 2 weeks and prescribe Prednisone if she is still having the symptoms.
Pt recvd MMR vax on 23FEB88 & 21JAN91 pt was seen for intermittent fever, diarrhea, dec in appetite, vomiting, & lethargy; dx pneumonia; also dx poss measles;
Received injection - 4 or 5 days later developed neck spasms, difficulty holding head up, difficulty swallowing, pain on both sides of the neck, worsens as the day progresses. Received vaccine on 2/23/05 due to a dog scratch that occurred on 2/20/05 the scratch caused a 4" cut on left arm of patient.
Received vaccines on 10/10/17, by the evening was running fever 103.5, complaining of headache, and redness at injection site. Area not tender or hot to touch. No signs of infection. Treatment to included TYLENOL prn and cool compress to area.
12 minutes after administering the vaccine, the client started feeling dizzy and lightheaded.  Pt states she did well with the 1st vaccine and only experienced a sore arm.  Pt walked to the fridge to get a bottle of water and she kept saying she felt dizzy.  Pt appeared as if she would pass out so she was assisted to her nearby chair.  I assessed pt and noticed she had weak radial pulses.  Her pulses were irregular.  Pt states she has a history of A-fib.  Pt denies sob, chest pain or any other problems.  No urticaria noted to pt's body.  Pt's skin was dry and warm.  Pt's color was a little pale.  911 called.  Pt's blood pressure while sitting is 200/98.  Pt remained stable while waiting Medic's arrival and she continued to deny any other problems.  She states she stills feels very dizzy and is adamant she felt fine and completely normal prior to getting the vaccine.  Medic arrived on scene, obtained vitals and 12 lead EKG and pt was transported to ED.
On 8/9/94, the pt experienced a tonic clonic seizure. Seizures again on 8/21/95 and 9/6/95. Put on Tegretol. Had some delays in learning, fine and gross motor skills before first seizure. These delays became more pronounced after.
Site: Pain at Injection Site-Mild, Systemic: Fever-Mild, Systemic: Pin the throat/ear and back (only on right side) , coughing -Mild, Additional Details: patient complaining of pain in the back on the right side since Day 1. Fever developed on 2nd day, but recovered. Also pain in throat/ear, stuffy nose, and coughing, but minor.
I developed neuropathy under my breasts and stomach; Have lost 20 pounds because I can't hardly eat; I can't hardly eat because of the neuropathy; I am very unhappy / will join a class action lawsuit; This case was reported by a consumer and described the occurrence of neuropathy in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced neuropathy (serious criteria GSK medically significant), weight loss, unable to eat and depressed mood. The patient was treated with gabapentin. On an unknown date, the outcome of the neuropathy, weight loss, unable to eat and depressed mood were unknown.   The reporter considered the neuropathy, weight loss, unable to eat and depressed mood to be possibly related to Shingrix.  Additional details were reported as follows: This case was reported by patient himself/herself via email. The age group was not reported but was selected as an adult as per vaccine indication. The age at vaccination was not reported. The patient wanted to protect itself from shingles, so received Shringrix vaccine 5 months ago and developed neuropathy under his/her breasts and stomach, had lost 20 pounds because he/she could not hardly eat because of the neuropathy. The patient spoke to his/her doctor and he said it was very likely that he/she received it from the vaccine, and He had prescribed Gabapentin. The patient was very unhappy and would join a class action lawsuit. The patient stated his/her life had changed forever, and none of his/her family members have had neuropathy and he/she fair warned them about this shot.
Had meningococcal vaccine at office. Mother notified our office pt "out of it". Couldn't hold head up. Advised to be seen in ED. Evaluated at ER.
This spontaneous report as received from a physician assistant refers to a male patient of unknown age. On 23-SEP-2013, (reported as at their twelve month visit), the patient was vaccinated with PROQUAD and  M-M-R II, (lot number and expiration date unknown), dose, route and anatomical location unspecified. It was reported that there was no product confusion, just a medication error. No adverse event was reported. Additional information is not expected.
This spontaneous report was received from a pharmacy technician referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On 15-MAR-2018, the patient was vaccinated with an expired dose of ZOSTAVAX subcutaneous route (dose, frequency, and anatomical location were unknown) with lot # N003697 and expiration date 13-MAR-2018 for prophylaxis. It was confirmed that ZOSTAVAX did not undergo a temperature excursion, and no adverse effects were reported.
POST VACCINE, BECAME DIZZY, HEART RACING. BROUGHT TO OBS VIA W.C. AT 1145. WATER GIVEN, LAYING DOWN, VSS, S/S RESOLVED SOON AFTER. ESCORTED TO EXIT VIA WHEELCHAIR WITHOUT ISSUES AT 1215 WITH FAMILY MEMBER. 1145 INITIAL BP 152/91 HR 84 SATS 97% RA 1200 BP 153/96 HR 81 SATS 99% RA 1210 BP 150/102 HR 88 SATS 97% (INSTRUCTED TO MONITOR BP AT HOME WITH AUTO CUFF AND CALL PCP IF DOESNT IMPROVE PER ONSITE MD INSTRUCTIONS, ASSYMPTOMATIC; STATES ANXIETY INDUCED.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with MMR II (Lot # not provided) (dose, route not provided). No other co-suspects were reported. No concomitant therapy was reported. The nurse practitioner reported that a serologic testing was performed and determined a negative titer for mumps. Additional information has been requested.
Throat irritation like it was closing. HR elevated to 120-130.  Clear airway with no wheezing, no stridor. Gave 25 mg Benadryl IM but then patient started coughing. Again checked airway, clear with normal lung sounds however with elevated heart rate, persistent coughing, called 911.
J96.00 ACUTE RESPIRATORY FAILURE 7/14/2022 ENCOUNTER FOR PALLIATIVE CARE
This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team, Program ID: Unknown. The reporter is the patient. A 65-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Lot number: FF8839) for Covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU taken for immunisation. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: GUILLAIN-BARRE SYNDROME (medically significant), outcome "unknown"; MUSCLE FATIGUE (non-serious), outcome "unknown"; PAIN (non-serious), outcome "unknown", described as "painful"; MUSCULAR WEAKNESS (non-serious), PAIN IN EXTREMITY (non-serious), outcome "unknown" and all described as "severe pain and weakness in legs"; GAIT INABILITY (non-serious), outcome "unknown", described as "unable to walk"; INFLAMMATION (non-serious), outcome "unknown", described as "MRI of right knee showed inflammation"; WALKING DISABILITY (non-serious), outcome "unknown", described as "3 days started having severe pain and weakness in legs, within 2 weeks was unable to walk. 6 months later am still weak, muscle fatigue, painful"; ASTHENIA (non-serious), outcome "unknown", described as "weak". The patient underwent the following laboratory tests and procedures: Magnetic resonance imaging: knee inflammation, notes: MRI of right knee showed inflammation but not much else. Clinical source: Patient received the Pfizer booster at the same time as the flu shot and within 3 days started having severe pain and weakness in legs, within 2 weeks was unable to walk. 6 months later patient was still weak, muscle fatigue, painful. Concerned may have Guillain-Barre syndrome. Her physician assistant know 6+ months of being weak, unsteady, in pain was not normal. Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the event and suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Patient is fully vaccinated. COVID + on 11/16/2021.  ED visit on 11/24/2021.  Presented with SOB.  44-year-old female presents ED for some mild chest discomfort and abnormal outpatient labs. According to patient primary care physician ordered multiple d-dimer levels on her which were trending upwards. Instructed to come to the ED for CTA. She denies additioanl symptoms at this time and states she has been feeling better since diagnosis. CT negative for evidence of PE. Vital signs within acceptable limits, not requiring supplemental oxygen. Treatment:  nitrogycerine SL.  asprin. iopamidol injection. SPO2 98%. Discharged to home. To return to ED with any new or worsening symptoms. Patient will follow up with PCP. Patient in stable condition with stable vitals for discharge and outpatient follow up.
Frequent instances of memory / cognitive function degraded. Difficulty remembering things on short-term and occasional long-term. Symptoms began within a month of taking the second dose of vaccine.